A carregar...
Management of Antiviral Resistance in Chronic Hepatitis B
The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint to discontinue treatment. However, HBsAg seroclearance occurs very rarely with nucleos(t)ide analo...
Na minha lista:
| Publicado no: | Gut Liver |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial Office of Gut and Liver
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347642/ https://ncbi.nlm.nih.gov/pubmed/28183162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl15562 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|